FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Thurston

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Living Beings

Infants

Activities & Behaviors

Consumer Product Safety

Co-author Network

Publications

TOP 3
Donald V Belsito; Joseph F Fowler; James G Marks; David M Pariser; Jon M Hanifin; Ida Alzira Gomes Duarte; Mario C Pires; Ponciano D Cruz; Richard G B Langley; Premal Patel; Christopher Bush; Mark Thurston; Michael Graeber; Robert Cherill
Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.
Vincent C Ho; Aditya Gupta; Roland Kaufmann; Gail Todd; Francisco Vanaclocha; Roberto Takaoka; Regina Fölster-Holst; Paul Potter; Katharine Marshall; Mark Thurston; Christopher Bush; Robert Cherill
Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.
Alexander Kapp; Kim A Papp; Ann Bingham; Regina Fölster-Holst; Jean-Paul Ortonne; Paul C Potter; Wayne Gulliver; Carle Paul; Stephen Molloy; Nathalie Barbier; Mark Thurston; Yves de Prost
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Thurston (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Donald V Belsito; Joseph F Fowler; James G Marks; David M Pariser; Jon M Hanifin; Ida Alzira Gomes Duarte; Mario C Pires; Ponciano D Cruz; Richard G B Langley; Premal Patel; Christopher Bush; Mark Thurston; Michael Graeber; Robert Cherill
Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.
Cutis; cutaneous medicine for the practitioner 2004;73(1):31-8.
2003: Vincent C Ho; Aditya Gupta; Roland Kaufmann; Gail Todd; Francisco Vanaclocha; Roberto Takaoka; Regina Fölster-Holst; Paul Potter; Katharine Marshall; Mark Thurston; Christopher Bush; Robert Cherill
Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.
The Journal of pediatrics 2003;142(2):155-62.
2002: Alexander Kapp; Kim A Papp; Ann Bingham; Regina Fölster-Holst; Jean-Paul Ortonne; Paul C Potter; Wayne Gulliver; Carle Paul; Stephen Molloy; Nathalie Barbier; Mark Thurston; Yves de Prost
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.
The Journal of allergy and clinical immunology 2002;110(2):277-84.
2001: Thomas Luger; Edwin J M Van Leent; Michael Graeber; S Hedgecock; Mark Thurston; A Kandra; John Berth-Jones; J Bjerke; Enno Christophers; J Knop; A C Knulst; M Morren; A Morris; Sakari Reitamo; J Roed-Petersen; E Schoepf; Kristian Thestrup-Pedersen; P G Van Der Valk; Jan D Bos
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis.
The British journal of dermatology 2001;144(4):788-94.
2001: Jon M Hanifin; Mark Thurston; M Omoto; Robert Cherill; Susan J Tofte; M Graeber
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.
Experimental dermatology 2001;10(1):11-8.
2000: Catherine Queille-Roussel; Michael Graeber; Mark Thurston; JM Lachapelle; J Decroix; C de Cuyper; Jean-Paul Ortonne
SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge.
Contact dermatitis 2000;42(6):349-50.
1998: Ulrich Mrowietz; Michael Graeber; Matthias Bräutigam; Mark Thurston; A Wagenaar; Gottfried Weidinger; Enno Christophers
The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion.
The British journal of dermatology 1998;139(6):992-6.
1998: Edwin J M Van Leent; M Gräber; Mark Thurston; A Wagenaar; Phyllis I Spuls; Jan D Bos
Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis.
Archives of dermatology 1998;134(7):805-9.